@article{73760f038be44f3cb804be8ada7f009f,
title = "2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome",
author = "Lin Chang and Heitkemper, {Margaret M.} and Wiley, {John W.} and Michael Camilleri",
note = "Funding Information: Conflicts of interest These authors disclose the following conflicts: Lin Chang has served on scientific advisory boards for Takeda, AstraZeneca, Allergan, QOL Medical, Ardelyx, Synergy, Commonwealth Laboratories, Ironwood, Synthetics Biologics, and IM Health Science. John Wiley is recipient of a research grant from Takeda Pharmaceuticals. Michael Camilleri has received research support in the field of IBS in the past 3 years from Tsumura, Salix, and EnteraHealth, and he has done consulting in the field of IBS in the past 3 years with GlaxoSmithKline with remuneration to his employer, Mayo Clinic. The remaining author discloses no conflicts. ",
year = "2016",
month = jul,
day = "1",
doi = "10.1053/j.gastro.2016.05.010",
language = "English (US)",
volume = "151",
pages = "e1--e8",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "1",
}